Nektar Therapeutics (NKTR) FCF Margin (2010 - 2026)
Nektar Therapeutics' FCF Margin was -748.83% in Q2 2026, down 339.21 percentage points from -409.62% a year earlier and down 340.80 percentage points from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) FCF Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nektar Therapeutics' FCF Margin was -428.72% through Jun 30, 2026, down 180.40 percentage points year-over-year; for FY2025, it came in at -377.83%, down 197.82 percentage points from FY2024.
- FCF Margin shows a five-year change of -168.21 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -180.01% in FY2024 (+34.67 pp), -214.68% in FY2023 (+121.73 pp), -336.41% in FY2022 (+83.24 pp) and -419.65% in FY2021 (-210.02 pp).
- The Q2 2026 figure marks the lowest quarterly FCF Margin in data going back to Q1 2010.
- Compared with a year earlier, FCF Margin was higher in two of the last eight quarters, with an average year-over-year change of -139.18 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q4 2022 (a gain of 365.17 percentage points); the worst was Q2 2026 (a drop of 339.21 percentage points).
- Per Business Quant data, NKTR's FCF Margin in the three quarters before Q2 2026 was -408.03% (Q1 2026), -297.96% (Q4 2025) and -414.55% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | -748.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -748.83% |
| Mar 31, 2026 | -408.03% |
| Dec 31, 2025 | -297.96% |
| Sep 30, 2025 | -414.55% |
| Jun 30, 2025 | -409.62% |
| Mar 31, 2025 | -468.98% |
| Dec 31, 2024 | -159.88% |
| Sep 30, 2024 | -184.87% |
| Jun 30, 2024 | -161.30% |
| Mar 31, 2024 | -222.03% |
| Dec 31, 2023 | -197.97% |
| Sep 30, 2023 | -174.59% |
| Jun 30, 2023 | -252.13% |
| Mar 31, 2023 | -242.42% |
| Dec 31, 2022 | -264.34% |
| Sep 30, 2022 | -351.61% |
| Jun 30, 2022 | -351.04% |
| Mar 31, 2022 | -373.16% |
| Dec 31, 2021 | -629.51% |
| Sep 30, 2021 | -417.61% |
API Access
Nektar Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();